0001209191-23-052997.txt : 20231017 0001209191-23-052997.hdr.sgml : 20231017 20231017183753 ACCESSION NUMBER: 0001209191-23-052997 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231016 FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burgess Michael F. CENTRAL INDEX KEY: 0001801745 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41747 FILM NUMBER: 231330577 MAIL ADDRESS: STREET 1: C/O SYNLOGIC, INC. STREET 2: 301 BINNEY STREET, SUITE 402 CITY: CAMRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Turnstone Biologics Corp. CENTRAL INDEX KEY: 0001764974 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832909368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 347-897-5988 MAIL ADDRESS: STREET 1: 920 BROADWAY STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-16 0 0001764974 Turnstone Biologics Corp. TSBX 0001801745 Burgess Michael F. C/O TURNSTONE BIOLOGICS CORP. 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 1 1 0 0 Interim Chief Medical Officer 0 Employee Stock Option (Right to Buy) 2.61 2023-10-16 4 A 0 11464 0.00 A 2033-10-15 Common Stock 11464 11464 D One fourth (1/4th) of the shares subject to the option award shall vest on October 12, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date. /s/ P. Joseph Campisi, Jr., Attorney-in-Fact 2023-10-17